Risk–Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults

Journal of Adolescent and Young Adult Oncology , Vol. 0, No. 0.


http://ift.tt/2dUimR5